Funding for this research was provided by:
BrightFocus Foundation (A2018149F)
National Institutes of Health (U01AG046139, R01AG018454, P50AG047266)
Article History
Received: 7 August 2019
Accepted: 13 November 2019
First Online: 2 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: TEG is a founder of Lacerta Therapeutics.